US FDA’s Narrow Path For Imports: Beware The 'SIP'-pery Slope

Newly proposed pathway to allow states to pursue wholesale importation of drugs from Canada is extremely narrow and restrictive, at least in draft form. It is still a terrible precedent for industry – one that can be easily expanded if it takes effect.